Semi-Annual Consolidated Statement Of Income

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7728466

Concept 2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
11,495,901,000 JPY
-141,641,000 JPY
1,306,725,000 JPY
33,382,000 JPY
9,522,491,000 JPY
693,902,000 JPY
11,637,543,000 JPY
81,042,000 JPY
11,556,501,000 JPY
11,553,570,000 JPY
2,054,904,000 JPY
8,968,554,000 JPY
6,549,000 JPY
540,887,000 JPY
75,192,000 JPY
11,646,086,000 JPY
-92,516,000 JPY
11,570,894,000 JPY
Cost of sales
8,314,805,000 JPY
9,064,464,000 JPY
Ordinary profit (loss)
-921,042,000 JPY
-1,832,745,000 JPY
Gross profit (loss)
3,181,095,000 JPY
2,489,105,000 JPY
Extraordinary income
483,849,000 JPY
165,146,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
4,365,278,000 JPY
4,585,273,000 JPY
Extraordinary losses
937,463,000 JPY
50,129,000 JPY
Profit (loss) before income taxes
-1,374,656,000 JPY
-1,717,728,000 JPY
Operating profit (loss)
-1,184,182,000 JPY
-13,764,000 JPY
110,436,000 JPY
-159,691,000 JPY
-1,158,048,000 JPY
1,138,000 JPY
-1,170,417,000 JPY
35,746,000 JPY
-1,206,164,000 JPY
-2,096,167,000 JPY
5,294,000 JPY
-1,899,587,000 JPY
-195,411,000 JPY
-43,457,000 JPY
3,402,000 JPY
-2,129,758,000 JPY
33,591,000 JPY
-2,133,161,000 JPY
Income taxes - current
108,265,000 JPY
161,899,000 JPY
Non-operating income
Interest income
13,436,000 JPY
14,482,000 JPY
Dividend income
0 JPY
2,456,000 JPY
Share of profit of entities accounted for using equity method
513,338,000 JPY
JPY
Non-operating income
691,145,000 JPY
683,825,000 JPY
Income taxes - deferred
436,452,000 JPY
-86,433,000 JPY
Non-operating expenses
Interest expenses
284,296,000 JPY
279,979,000 JPY
Share of loss of entities accounted for using equity method
JPY
48,367,000 JPY
Non-operating expenses
428,005,000 JPY
420,403,000 JPY
Income taxes
544,718,000 JPY
75,465,000 JPY
Extraordinary income
Gain on sale of non-current assets
5,150,000 JPY
5,817,000 JPY
Profit (loss)
-1,919,375,000 JPY
-1,793,193,000 JPY
Extraordinary losses
Loss on sale of non-current assets
8,364,000 JPY
5,987,000 JPY
Impairment losses
1,250,000 JPY
8,164,000 JPY
Profit (loss) attributable to non-controlling interests
22,020,000 JPY
-8,784,000 JPY
Profit (loss) attributable to owners of parent
-1,941,395,000 JPY
-1,784,408,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
3,284,705,000 JPY
6,141,875,000 JPY
Foreign currency translation adjustment
-398,771,000 JPY
-2,601,193,000 JPY
Share of other comprehensive income of entities accounted for using equity method
38,993,000 JPY
-19,886,000 JPY
Other comprehensive income
2,924,926,000 JPY
3,520,795,000 JPY
Comprehensive income
1,005,551,000 JPY
1,727,601,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
983,087,000 JPY
1,734,187,000 JPY
Comprehensive income attributable to non-controlling interests
22,464,000 JPY
-6,585,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.